LIVE TV
ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Budget 2021
  • Personal Finance
    • PPF
    • Mutual Funds
    • Income tax
    • EPFO
    • Income Tax Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • Home Loan Calculator
    • SIP calculator
    • SWP Calculator
    • MF Returns Calculator
    • Lumpsum Calculator
  • India
    • Companies
    • Property
    • Startups
    • Uidai
  • Economy
    • Aviation
  • Tech
    • Mobiles
    • Apps
  • Auto
    • Cars
    • Bikes
  • Markets
    • Commodities
    • Currency
  • Jobs
  • Indian Railways
  • World
    • Economy
    • Politics
    • Markets
  • videos
  • photos
  • Authors
  • More ...
    • VIDEOS
    • PHOTOS
Read in App
Business News » Companies News

EU recommends suspending hundreds of drugs tested by Indian firm

In 2015, Europe banned around 700 medicines that had been approved based on clinical trial data provided by GVK Biosciences, then India’s largest CRO.

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App
EU recommends suspending hundreds of drugs tested by Indian firm
The EMA`s recommendation will now be sent to the European Commission. Photo: Pixabay
Written By: Reuters
Updated: Sat, Mar 25, 2017
05:44 pm
London, Reuters

Europe`s medicines regulator has recommended the suspension of more than 300 generic drug approvals and drug applications due to "unreliable" tests conducted by Indian contract research firm Micro Therapeutic Research Labs.

The decision, announced by the European Medicines Agency (EMA) on its website, is the latest blow for India`s drug-testing industry, which has run into a series of problems with international regulators in recent years.

Nobody at the Chennai-based company was immediately available to comment. The EMA said European officials had been investigating Micro Therapeutic`s compliance with good clinical practice after Austrian and Dutch authorities raised concerns in February 2016.

"The inspections identified several concerns at the company’s sites regarding misrepresentation of study data and deficiencies in documentation and data handling," the agency said.

However, there is no evidence of harm or lack of effectiveness of the medicines, which include generic versions of many common prescription pharmaceuticals, including blood pressure tablets and painkillers.

The EMA`s recommendation on the suspension of the medicines tested by Micro Therapeutic will now be sent to the European Commission for a legally binding decision valid throughout the European Union.

Drug tests carried out at Indian contract research organisations (CROs) have been key in getting a huge array of generic medicines approved for sale around the world over many years.

In 2015, Europe banned around 700 medicines that had been approved based on clinical trial data provided by GVK Biosciences, then India’s largest CRO. Other smaller Indian CROs have also been found to have fallen short of required standards.

In the wake of such trial data scandals, many large drugmakers have been shifting more critical trials back to the United States and Europe over the last three years, according to consultants and industry executives.

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
Micro Therapeutic Research LabsEuropean Medicines Agency (EMA)PharmaMicro TherapeuticDrugsIndian contract research organisations (CROs)GVK BiosciencesEuropean Commission
RELATED NEWS

LATEST NEWS

Rakesh Jhunjhunwala Stocks: Experts bet big on these two stocks with bumper returns

Cipla is the TOP gainer on Nifty today; expert pegs price target between Rs 950-Rs 1000 going forward

MASSIVE discount of Rs 40,000 on LG Wing, set to be priced at Rs 29,990 on Flipkart- Check all details here

In chat with Anil Singhvi, analyst Vikas Sethi recommends Divi's Lab, Infosys as top buys for big gains

Dr Lal Pathlabs outperformed its peers even as markets plummeted; Analyst Simi Bhaumik recommends a Buy for this target price

Maharashtra Board Class 10, Class 12 exams postponed—Check what minister said about CBSE, ICSE, IB and Cambridge boards

Stocks to Buy With Anil Singhvi: This company can generate good returns for investors - what Varinder Bansal said

TCS, Infosys, MindTree – Ahead of TCS result what to do with this stock? Profit booking seen in Infosys, Mindtree

Delhi Schools and Colleges Latest News: All educational institutes closed, class 9 class 11 exams POSTPONED - Important message from Manish Sisodia

Haridwar Kumbh Mela 2021: 2nd Shahi Snan today; Mela inspector says difficult to ensure social distancing at 'Har Ki Pauri'

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
Copyright © Zee Media Corporation Ltd. All rights reserved